Akzo Nobel minority shareholders dealt body blow by abstaining Fund

Minority shareholders of Akzo Nobel who put up a valiant fight against the merger of group companies lost at the end by a wafer thin margin. The MNC was merging three group companies with the listed company and the minority shareholders were protesting the valuations given to these companies. UTI did not vote and the reason attributed to the same was the absence of a CEO in the company.

The decision of UTI not to vote cost the minority shareholders the battle as they failed to get the required votes to block a resolution enabling the merging of the group companies. Had UTI voted along with the other minority domestic institutions, the resolution would have gained the required votes to be blocked.

This action or no stand taken by UTI or for that matter by any institution again opens up the debate on mutual funds or domestic institutions and their stand on key issues. It has been seen that domestic institutions abstain from taking any stand on such issues. At best they have been seen to exiting the company and selling their shares. Selling of shares is no solution as the institution has a moral right to its unit holders to act in their best interest, and that best interest can only be achieved or served by taking a stand. This certainly cannot be achieved by selling shares or being neutral.

Shareholder activism has been dealt a body blow by this actionof a mutual fund as this has been against the interest of minority shareholders. This would lead many retail investors to believe that their interest is best taken care of by being shareholders directly and not through mutual funds.

There have been suggestions/directives from the regulator that the fund must take a stand and vote on crucial matters and post the same on their website. At best this remains so only on paper. The regulator must now lay down some more norms where there should be penal action against a fund who abstains in such crucial matters and also allow the unit holders of the scheme to take action against the fund. The simple answer of yester years would be you don’t like what we did; sell or exit the scheme is no longer valid either from the fund manager or the unit holder. It’s time the regulator takes firm action on this matter as going forward there will be many cases where minority shareholders would have to stand up and fight for their rights against MNC’s and other managements.

One hopes this is an eye opener for one and all and the unit holders of the particular scheme who were apparently involved in this defeat of minority shareholders be taken to task. The fund manager concerned should be asked his stand and what he did on the issue. It would be interesting as to what the fund writes about this stand on their website.

Anyway let’s hope the management of Akzo Nobel realises its narrow victory on a case of abstention by a fund on technical ground and respects the sentiment echoed by minority shareholders. It would be important for them to appreciate the resentment against the same and one hopes that in their proposal for share buyback from minority shareholders and review of the royalty arrangement, they are fair and just. Though the minority shareholders have lost the case they have won by uniting and demonstrating their power. This should also force mutual funds to become more active in safeguarding the interests of their investors.

Though minority shareholders lost they have won a moral victory simply because they came so close and lost because of abstention. The icing on the cake would be if minority shareholders are given a fair price on the buy back.

Performance of Newly Listed Shares as on 10th February 2012

These IPO’s were listed during the July September 2011 quarter

Name Date of Listing Issue Price Closing  Price Closing Price % Gain Loss  Change Over Lifetime   Fall from  Fall as % from
10th Feb 3rd Feb Over Week  Issue Price High High in Rs Lifetime High
Birla Pacific Medspa 7thJuly 10.00 7.50 7.42 1.08 -25.00 30.70 -23.20 -232.00
Rushil Décor 7thJuly 72.00 174.75 163.75 6.72 142.71 207.00 -32.25 -44.79
Readymade Steel India 13th July 108.00 60.30 61.20 -1.47 -44.17 117.75 -57.45 -53.19
Bhartiya Global Infomedia 28th July 82.00 9.18 8.87 3.49 -88.80 84.00 -74.82 -91.24
Inventure Growth & Securities 4th Aug 117.00 219.10 203.40 7.72 87.26 256.75 -37.65 -32.18
L&T Finance Holdings 12th Aug 52.00 48.35 48.40 -0.10 -7.02 53.00 -4.65 -8.94
Tree House Education & Acessories 26th Aug 135.00 224.55 215.90 4.01 66.33 211.80 12.75 9.44
Brooks Laboratories 5th Sept 100.00 21.33 13.97 52.68 -78.67 131.10 -109.77 -109.77
TD Power Systems 8th Sept 256.00 251.35 250.50 0.34 -1.82 321.00 -69.65 -27.21
SRS  16th Sept 58.00 33.70 34.50 -2.32 -41.90 61.40 -27.70 -47.76
PG Electroplast 26th Sept 210.00 193.05 179.75 7.40 -8.07 548.00 -354.95 * -169.02

* I have received lot of queries about the last column “fall as % from lifetime high” and the fact that it is more than 100%. The fact is that many of these poor fundamental shares have gone up sharply on the day of listing or for a brief period and then have fallen sharply. The base of all issues is the issue price and because a share cannot trade at negative value it can never fall more than 99%.

This column highlights the extent of fall from the lifetime high and depicts the same as a percentage of the issue price.

For example in the case of Birla Medspa the high is Rs 30.70 which is a gain of 307% on the issue price and the share has fallen below the issue price of Rs 10 to now trade at Rs 6.78. This translates into the loss of 239.20% from the lifetime high.

Performance of Newly Listed Shares as on 3rd February 2012

These IPO’s were listed during the October December 2011 quarter

Name Date of Listing Issue Price Closing  price Closing Price % Gain Loss  Change Over Lifetime   Fall from  Fall as % of
3rd Feb 27th Jan Over Week  Issue Price High High in Rs Issue Price
Prakash Constrowell 4th Oct 138.00 124.20 139.30 -10.84 -10.00 311.70 -187.50 -135.87
RDB Rasayans 7th Oct 79.00 7.92 8.17 -3.06 -89.97 93.15 -85.23 -107.89
Tijaria Polypipes 14th Oct 60.00 8.9 8.66 2.77 -85.17 67.80 -58.90 -98.17
Onelife Capital Advisors 17th Oct 110.00 297.5 259.05 14.84 170.45 309.35 -11.85 -10.77
Flexituff International 19th Oct 155.00 274.8 250.85 9.55 77.29 301.95 -27.15 -17.52
Taksheel Solutions 19th Oct 150.00 13.33 13.55 -1.62 -91.11 185.00 -171.67 -114.45
M&B Switchgear 20th Oct 186.00 68.6 64.65 6.11 -63.12 390.00 -321.40 -172.80
Vaswani Industries 24th Oct 39.20 11.56 11.01 5.00 -70.51 35.40 -23.84 -60.82
Indo – Thai Securities 2nd Nov 74.00 12.70 12.74 -0.31 -82.84 99.10 -86.40   *  -116.76

* I have received lot of queries about the last column “fall as % from lifetime high” and the fact that it is more than 100%. The fact is that many of these poor fundamental shares have gone up sharply on the day of listing or for a brief period and then have fallen sharply. The base of all issues is the issue price and because a share cannot trade at negative value it can never fall more than 99%.

This column highlights the extent of fall from the lifetime high and depicts the same as a percentage of the issue price.

For example in the case of Birla Medspa the high is Rs 30.70 which is a gain of 307% on the issue price and the share has fallen below the issue price of Rs 10 to now trade at Rs 6.78. This translates into the loss of 239.20% from the lifetime high.

Subscribe to RSS Feed Follow me on Twitter!